Literature DB >> 16441916

Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats.

Manal Abd El Mohsen1, Joanne Marks, Gunter Kuhnle, Kevin Moore, Edward Debnam, S Kaila Srai, Catherine Rice-Evans, Jeremy P E Spencer.   

Abstract

Recent reports have demonstrated various cardiovascular and neurological benefits associated with the consumption of foods rich in anthocyanidins. However, information regarding absorption, metabolism, and especially, tissue distribution are only beginning to accumulate. In the present study, we investigated the occurrence and the kinetics of various circulating pelargonidin metabolites, and we aimed at providing initial information with regard to tissue distribution. Based on HPLC and LC-MS analyses we demonstrate that pelargonidin is absorbed and present in plasma following oral gavage to rats. In addition, the main structurally related pelargonidin metabolite identified in plasma and urine was pelargonidin glucuronide. Furthermore, p-hydroxybenzoic acid, a ring fission product of pelargonidin, was detected in plasma and urine samples obtained at 2 and 18 h after ingestion. At 2 h post-gavage, pelargonidin glucuronide was the major metabolite detected in kidney and liver, with levels reaching 0.5 and 0.15 nmol pelargonidin equivalents/g tissue, respectively. Brain and lung tissues contained detectable levels of the aglycone, with the glucuronide also present in the lungs. Other tissues, including spleen and heart, did not contain detectable levels of pelargonidin or ensuing metabolites. At 18 h post-gavage, tissue analyses did not reveal detectable levels of the aglycone nor of pelargonidin glucuronides. Taken together, our results demonstrate that the overall uptake of the administered pelargonidin was 18 % after 2 h, with the majority of the detected levels located in the stomach. However, the amounts recovered dropped to 1.2 % only 18 h post-gavage, with the urine and faecal content constituting almost 90 % of the total recovered pelargonidin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441916     DOI: 10.1079/bjn20051596

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  34 in total

1.  Flavonoids in modulation of cell survival signalling pathways.

Authors:  Mohammad Lukman Mansuri; Priyanka Parihar; Isha Solanki; Mordhwaj S Parihar
Journal:  Genes Nutr       Date:  2014-03-30       Impact factor: 5.523

2.  Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations.

Authors:  Sebastian Schaffer; Barry Halliwell
Journal:  Genes Nutr       Date:  2011-10-20       Impact factor: 5.523

3.  Impact of the quantity and flavonoid content of fruits and vegetables on markers of intake in adults with an increased risk of cardiovascular disease: the FLAVURS trial.

Authors:  Mary F Chong; Trevor W George; Dauren Alimbetov; Yannan Jin; Michelle Weech; Anna L Macready; Jeremy P E Spencer; Orla B Kennedy; Anne-Marie Minihane; Michael H Gordon; Julie A Lovegrove
Journal:  Eur J Nutr       Date:  2012-04-03       Impact factor: 5.614

4.  Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Authors:  Stephen W Scheff; Mubeen A Ansari; Kelly N Roberts
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

Review 5.  Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria.

Authors:  Sebastian Schaffer; Heike Asseburg; Sabine Kuntz; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-17       Impact factor: 5.590

6.  Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1.

Authors:  A Dreiseitel; B Oosterhuis; K V Vukman; P Schreier; A Oehme; S Locher; G Hajak; P G Sand
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

7.  sPhospholipase A(2) is inhibited by anthocyanidins.

Authors:  Andrea Dreiseitel; Gabriele Korte; Peter Schreier; Anett Oehme; Sanja Locher; Goeran Hajak; Philipp G Sand
Journal:  J Neural Transm (Vienna)       Date:  2009-08-01       Impact factor: 3.575

8.  Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Authors:  Donatella Perrone; Maria Pia Fuggetta; Fatima Ardito; Andrea Cottarelli; Anna De Filippis; Giampietro Ravagnan; Salvatore De Maria; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

Review 9.  NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.

Authors:  Saumitra Sen Singh; Sachchida Nand Rai; Hareram Birla; Walia Zahra; Aaina Singh Rathore; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-12-10       Impact factor: 3.911

Review 10.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Authors:  Daniele Del Rio; Ana Rodriguez-Mateos; Jeremy P E Spencer; Massimiliano Tognolini; Gina Borges; Alan Crozier
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.